Inibizione della progressione del danno strutturale articolare con upadacitinib nell'artrite reumatoide: risultati a 1 anno dal programma SELECT di fase 3
Rheumatology (Oxford). 2021. Epub ahead of print. doi: 10.1093/rheumatology/keab861
Keywords:
Publications
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.